======= RBM24 ======= == Gene Information == * **Official Symbol**: RBM24 * **Official Name**: RNA binding motif protein 24 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=221662|221662]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BX46|Q9BX46]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RBM24&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RBM24|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617603|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in myogenic differentiation by regulating MYOG levels. Binds to the 3'-UTR of MYOG mRNA and regulates its stability. {ECO:0000269|PubMed:20977548}. |RRM 1| |mRNA CDS binding| |regulation of 3-UTR-mediated mRNA stabilization| |positive regulation of 3-UTR-mediated mRNA stabilization| |positive regulation of skeletal muscle fiber differentiation| |regulation of skeletal muscle fiber differentiation| |positive regulation of skeletal muscle cell differentiation| |negative regulation of cytoplasmic translation| |pre-mRNA intronic binding| |sequence-specific mRNA binding| |3-UTR-mediated mRNA destabilization| |regulation of skeletal muscle cell differentiation| |positive regulation of stem cell differentiation| |positive regulation of myoblast differentiation| |positive regulation of skeletal muscle tissue development| |mRNA 3-UTR AU-rich region binding| |regulation of cytoplasmic translation| |mRNA destabilization| |RNA destabilization| |positive regulation of myotube differentiation| |endocardial cushion development| |mRNA stabilization| |RNA stabilization| |positive regulation of mRNA catabolic process| |regulation of skeletal muscle tissue development| |negative regulation of mRNA catabolic process| |regulation of myoblast differentiation| |regulation of myotube differentiation| |positive regulation of striated muscle cell differentiation| |negative regulation of RNA catabolic process| |regulation of alternative mRNA splicing, via spliceosome| |positive regulation of muscle organ development| |positive regulation of striated muscle tissue development| |positive regulation of muscle tissue development| |mRNA 3-UTR binding| |positive regulation of mRNA metabolic process| |negative regulation of mRNA metabolic process| |positive regulation of muscle cell differentiation| |regulation of mRNA splicing, via spliceosome| |regulation of striated muscle cell differentiation| |regulation of stem cell differentiation| |negative regulation of translation| |regulation of striated muscle tissue development| |regulation of muscle tissue development| |regulation of muscle organ development| |regulation of RNA splicing| |regulation of mRNA processing| |negative regulation of cellular amide metabolic process| |regulation of muscle cell differentiation| |ribonucleoprotein complex| |mRNA binding| |regulation of mRNA stability| |regulation of RNA stability| |regulation of mRNA catabolic process| |mesenchyme development| |negative regulation of cellular catabolic process| |negative regulation of catabolic process| |regulation of mRNA metabolic process| |regulation of translation| |positive regulation of cellular catabolic process| |RNA splicing| |regulation of cellular amide metabolic process| |positive regulation of catabolic process| |mRNA processing| |posttranscriptional regulation of gene expression| |heart development| |mRNA metabolic process| |cellular response to DNA damage stimulus| |regulation of cellular catabolic process| |circulatory system development| |RNA processing| |positive regulation of cell differentiation| |regulation of catabolic process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |RNA metabolic process| |cellular response to stress| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of gene expression| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp306|Rapamycin 2μM R07 exp306]]|1.94| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18129 * **Expression level (log2 read counts)**: -2.28 {{:chemogenomics:nalm6 dist.png?nolink |}}